Anaesthesia and orphan disease: A child with Congenital Cataract Facial Dysmorphism neuropathy (CCFDN) syndrome: a case report.

IF 6.8 2区医学 Q1 ANESTHESIOLOGY European Journal of Anaesthesiology Pub Date : 2017-03-01 DOI:10.1097/EJA.0000000000000586

Oliver W. Masters, E. Bergmans, K. Thies

{"title":"Anaesthesia and orphan disease: A child with Congenital Cataract Facial Dysmorphism neuropathy (CCFDN) syndrome: a case report.","authors":"Oliver W. Masters, E. Bergmans, K. Thies","doi":"10.1097/EJA.0000000000000586","DOIUrl":null,"url":null,"abstract":"References 1 Molderings GJ, Homann J, Brettner S, et al. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Dtsch Med Wochenschr 2014; 139:1523–1534. 2 Carter MC, Uzzaman A, Scott LM, et al. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg 2008; 107:422–427. 3 Reddy JI, Cooke PJ, van Schalkwyk JM, et al. Anaphylaxis is more common with rocuronium and succinylcholin than with atracurium. Anesthesiology 2015; 122:39–45. 4 Levy JH, Davis GK, Duggan J, et al. Determination of the hemodynamics and histamine release of rocuronium (Org9426) when administered in increased doses under N2O/O2-sufentanil anesthesia. Anesth Analg 1994; 78:318–321. 5 Klein NJ, Misseldine S. Anesthetic considerations in pediatric mastocytosis: a review. J Anesth 2013; 27:588–598. 6 Gronert GA. Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology 2001; 94:523–529. 7 Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013–1022. 8 Ahmad N, Evans P, Lloyd-Thomas AR. Anesthesia in children with mastocytosis – a case based review. Paediatr Anaesth 2009; 19:97–107. 9 Takazawa T, Mitsuhata H, Mertes PM. Sugammadex and rocuroniuminduced anaphylaxis. J Anesth 2016; 30:290–297. 10 Dewachter P, Mouton-Faivre C, Cazalaa JB, et al. Mastocytosis and anaesthesia. Ann Fr Anesth 2009; 28:61–73. 11 Greenblatt EP, Chen L. Urticaria pigmentosa: an anesthetic challenge. J Clin Anesth 1990; 2:108–115.","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/EJA.0000000000000586","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Anaesthesiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/EJA.0000000000000586","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}

引用次数: 3

Abstract

References 1 Molderings GJ, Homann J, Brettner S, et al. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Dtsch Med Wochenschr 2014; 139:1523–1534. 2 Carter MC, Uzzaman A, Scott LM, et al. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg 2008; 107:422–427. 3 Reddy JI, Cooke PJ, van Schalkwyk JM, et al. Anaphylaxis is more common with rocuronium and succinylcholin than with atracurium. Anesthesiology 2015; 122:39–45. 4 Levy JH, Davis GK, Duggan J, et al. Determination of the hemodynamics and histamine release of rocuronium (Org9426) when administered in increased doses under N2O/O2-sufentanil anesthesia. Anesth Analg 1994; 78:318–321. 5 Klein NJ, Misseldine S. Anesthetic considerations in pediatric mastocytosis: a review. J Anesth 2013; 27:588–598. 6 Gronert GA. Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology 2001; 94:523–529. 7 Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013–1022. 8 Ahmad N, Evans P, Lloyd-Thomas AR. Anesthesia in children with mastocytosis – a case based review. Paediatr Anaesth 2009; 19:97–107. 9 Takazawa T, Mitsuhata H, Mertes PM. Sugammadex and rocuroniuminduced anaphylaxis. J Anesth 2016; 30:290–297. 10 Dewachter P, Mouton-Faivre C, Cazalaa JB, et al. Mastocytosis and anaesthesia. Ann Fr Anesth 2009; 28:61–73. 11 Greenblatt EP, Chen L. Urticaria pigmentosa: an anesthetic challenge. J Clin Anesth 1990; 2:108–115.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

麻醉与孤儿病：一例先天性白内障面部变形性神经病（CCFDN）综合征患儿的病例报告。

参考文献1 Molderings GJ，Homann J，Brettner S等。肥大细胞活化病：诊断和治疗选择的简明实用指南。Dtsch Med Wochenschr 2014；139:1523–1534。2 Carter MC，Uzzaman A，Scott LM等。小儿肥大细胞增多症：复杂疾病的常规麻醉管理。2008年分析；107:422–427.3 Reddy JI，Cooke PJ，van Schalkwyk JM等。罗库溴铵和琥珀酰胆碱的过敏反应比阿曲库铵更常见。麻醉学2015；122:39–45.4 Levy JH、Davis GK、Duggan J等人。在N2O/O2舒芬太尼麻醉下增加剂量给药时罗库（Org9426）的血液动力学和组胺释放的测定。1994年分析；78:318–321.5 Klein NJ，Misseldine S.小儿肥大细胞增多症的麻醉注意事项：综述。J Anesth 2013；27:588–598.6 Gronert GA。琥珀胆碱后心脏骤停：横纹肌溶解症的死亡率高于受体上调。麻醉学2001；94:523–529.7 Plaud B，Debaene B，Donati F等。麻醉苏醒后的残余麻痹。麻醉学2010；112:1013–1022.8 Ahmad N，Evans P，Lloyd Thomas AR。儿童肥大细胞增多症的麻醉——一项基于病例的综述。儿科Anaesth 2009；19:97–107.9 Takazawa T，Mitsuhata H，Mertes PM。Sugammadex和罗库过敏反应。J Anesth 2016；30:290–297.10 Dewachter P，Mouton Faivre C，Cazalaa JB等。肥大细胞增多症和麻醉。Ann Fr Anesth 2009；28:61–73.11 Greenblatt EP，Chen L.色素性荨麻疹：麻醉挑战。J Clin Anesth 1990；2:108–115。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

European Journal of Anaesthesiology 医学-麻醉学

CiteScore

6.90

自引率

11.10%

发文量

351

审稿时长

6-12 weeks

期刊介绍： The European Journal of Anaesthesiology (EJA) publishes original work of high scientific quality in the field of anaesthesiology, pain, emergency medicine and intensive care. Preference is given to experimental work or clinical observation in man, and to laboratory work of clinical relevance. The journal also publishes commissioned reviews by an authority, editorials, invited commentaries, special articles, pro and con debates, and short reports (correspondences, case reports, short reports of clinical studies).